| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000019612 |
| Receipt No. | R000022665 |
| Scientific Title | Efficacy of an ultrasound urine volume monitor (Lilium alpha-200) in evaluation of lower urinary tract dyfunction |
| Date of disclosure of the study information | 2015/11/02 |
| Last modified on | 2020/05/06 (Ver. 7) |
| Basic information | ||
| Public title | Efficacy of an ultrasound urine volume monitor (Lilium alpha-200) in evaluation of lower urinary tract dyfunction | |
| Acronym | Efficacy of an ultrasound urine volume monitor | |
| Scientific Title | Efficacy of an ultrasound urine volume monitor (Lilium alpha-200) in evaluation of lower urinary tract dyfunction | |
| Scientific Title:Acronym | Efficacy of an ultrasound urine volume monitor | |
| Region |
|
|
| Condition | ||
| Condition | benign prostate hyperplasia, neurogenic bladder | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | to assess the efficacy of an ultrasound urine volume monitor in evaluation of lower urinary tract dysfunction in patients with benign prostate hyperplasia or neurogenic bladder |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | consistency of voiding record obtained by an ultrasound urine volume monitor with voiding diary |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | hospitalized patients with urodynamically proven benign prostatic obstruction or neurogenicnbladder older than 20 years | |||
| Key exclusion criteria | patients with urinary retention, patients undergoing intermittent catheterization | |||
| Target sample size | 45 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Department of Urology, Nagoya University Graduate School of Medicne | ||||||
| Division name | Urology | ||||||
| Zip code | 466-8550 | ||||||
| Address | 65 Tsurumai-cho, Showa-ku, Nagoya | ||||||
| TEL | 052-744-2984 | ||||||
| gotoh@med.nagoya-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Nagoya University Graduate School of Medicne | ||||||
| Division name | Urology | ||||||
| Zip code | 466-8550 | ||||||
| Address | 65 Tsurumai-cho, Showa-ku, Nagoya | ||||||
| TEL | 052-744-2984 | ||||||
| Homepage URL | |||||||
| gotoh@med.nagoya-u.ac.jp | |||||||
| Sponsor | |
| Institute | Department of Urology, Nagoya University Graduate School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Liliam Otsuka |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Ethics Committee, Nagoya University Graduate School of Medicine |
| Address | 65 Tsurumai-cho, Nagoya |
| Tel | 0527442984 |
| gotoh@med.nagoya-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | To assess the voiding records for 24 hours (time to void, changes of bladder volume)by a ultrasound urine volume monitor (Lilium alpha-200) and a frequency-volume chart, and to measure residual urine volume.
Cohort study. All patients who consult Nagoya University and Ohita University hospitals and meet the inclusion cliteria will be included, between Dec.2015 and Dec. 2016. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000022665 |